{"Title": ["Alimera Sciences Inc (ALIM) Q1 2020 Earnings Call Transcript", "BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Amazon.com, Dish Network, GE, AMC Entertainment, Aurora Cannabis", "Alimera Sciences Inc (ALIM) Q4 2019 Earnings Call Transcript", "2 Healthcare Stocks Set to Rally into the New Year", "Will Alimera Sciences (ALIM) Report Negative Q4 Earnings? What You Should Know", "Alimera Sciences (ALIM) Reports Q3 Loss, Tops Revenue Estimates", "EyePoint (EYPT) Gets FDA Approval for Eye Therapy Yutiq", "Alimera Sciences Sees Hammer Chart Pattern: Time to Buy?", "Alimera Sciences Inc (ALIM) Q1 2020 Earnings Call Transcript", "Health Care Sector Update for 10/23/2017: ALIM,EXAC,DBVT", "The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences", "Alimera Sciences, Inc. (ALIM) Looks Good: Stock Up 12.8%", "Pre-Market Most Active for Aug 4, 2016 : NOK, CHK, AZN, SQ, CP, FOXA, BAC, GOLD, AAPL, ALIM, AMRN, XIV", "Alimera Sciences (ALIM) Shares March Higher, Can It Continue?", "Health Care Sector Update for 07/26/2016: RDY,ALIM,TKAI", "Health Care Sector Update for 07/26/2016: EXAS,ALIM,TKAI", "Alimera Stock Grew 25 Percent and It Is Just Getting Warmed Up", "New Strong Sell Stocks for April 21st", "New Strong Sell Stocks for April 18th", "New Strong Sell Stocks for April 12th", "New Strong Sell Stocks for March 31st", "New Strong Sell Stocks for March 21st", "New Strong Sell Stocks for March 16th", "New Strong Sell Stocks for March 7th", "Alimera Sciences (ALIM) Is in Oversold Territory: What's Next?", "Health Care Sector Update for 03/03/2016: ALIM,CRMD,SSH", "Health Care Sector Update for 01/05/2016: ALIM,CLRB,AKBA", "Alimera Sciences (ALIM) in Focus: Stock Rises 12.3%", "How the bulls are playing Alimera", "Is Alimera Sciences (ALIM) Stock a Solid Choice Right Now? - Tale of the Tape", "Health Care Sector Update for 03/05/2015: ALIM,EYES,MDBX", "Health Care Sector Update for 11/12/2014: CASI, OCUL, ALIM", "Closing Update: Markets Scratch Out Narrow Wins Ahead of Friday Payrolls Report for February", "Alimera/pSivida's Iluvien Receives FDA Approval for DME - Analyst Blog", "Alimera/pSivida Seek FDA Approval for Iluvien - Analyst Blog", "Strength Seen in Retrophin (RTRX): Stock Soars 49.8% - Tale of the Tape", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Synthetic Biologics (SYN) Slumps: Stock Tanks 11.4% - Tale of the Tape", "JNJ Beats on Earnings but Guides Below - Analyst Blog", "Alimera Sciences (ALIM) Jumps: Stock Up 7.5% - Tale of the Tape", "Pre-Market Most Active for Sep 29, 2014 : TIBX, ATHL, BABA, PBR, DWA, TVIX, AAPL, ECYT, JNS, SAN, BP, ALIM", "Cytori Therapeutics (CYTX) Soars: Stock Adds 11.4% in Session - Tale of the Tape", "Achillion Pharmaceuticals (ACHN) Surges: Stock Moves 13.3% Higher - Tale of the Tape", "Affymetrix's Revenue Guidance Tops Ests - Analyst Blog", "Athersys (ATHX) in Focus: Stock Moves 6.3% Higher - Tale of the Tape", "Patients Enrolled in Synageva Study - Analyst Blog", "Zacks #1 Rank Additions for Monday - Tale of the Tape", "Can The Uptrend Continue for Alimera Sciences Inc (ALIM)? - Tale of the Tape", "Zacks #1 Rank Additions for Wednesday - Tale of the Tape", "Sector Update: Healthcare Shares Lower Pre-Market; Vertex Sinks On Phase 3 Study of Ivacaftor", "Sector Update: Healthcare", "Update on pSivida's Iluvien - Analyst Blog", "Healthcare Stocks Closing Lower; Opko Sells Sorrento Therapeutics Stake For 10-Fold Gain on 2009 Investment", "Sector Update: Healthcare", "Healthcare Stocks in Decline; Oxygen Biotherapeutics Rallies on Plans to Bring Heart Drug to Late-Stage Trial", "Sector Update: Healthcare", "Alimera Sciences (ALIM) Soars: Stock Zooms 62.8% - Tale of the Tape", "Alimera Sciences Inc. is now in Oversold Territory - Tale of the Tape", "Alimera Down on 3rd Iluvien CRL - Analyst Blog", "pSivida: Thoughts In The Aftermath Of The Complete Response Letter On Iluvien", "Trade the Earnings: Alimera Sciences, Inc.", "pSivida Starts Phase III Study - Analyst Blog", "Draft Guidance from NICE for pSivida's Iluvien - Analyst Blog", "After-Hours Earnings Report for March 21, 2013 : NKE, SLW, MU, TIBX, RUE, NWY, ALIM", "Final Guidance from NICE for pSivida's Iluvien - Analyst Blog", "Limit Your Risk: Smart Money Stock Picks in Strong Cash Positions", "These 3 \"Forgotten\" IPOs Could Gain as Much as 50%", "Options Update: pSividia Calls Heat Up, Despite FDA-Related Drug Woes", "7 Beaten-Down IPOs that Could Stage a Comeback", "The Most Speculative Stocks on the Market", "Tuesday Winners: Worthington Industries, Smithfield Foods and Alimera Sciences", "These 'Broken' IPOs May be Worth another Look", "Smart Money: Cash-Rich Companies Boosted by Institutional and Insider Buying"], "Elapsed Time": ["APR 30, 2020", "APR 13, 2020", "FEB 27, 2020", "JAN 10, 2020", "FEB 20, 2019", "NOV 6, 2018", "OCT 17, 2018", "AUG 23, 2018", "APR 30, 2020", "OCT 23, 2017", "JUL 12, 2017", "MAR 14, 2017", "AUG 4, 2016", "JUL 27, 2016", "JUL 26, 2016", "JUL 26, 2016", "JUL 5, 2018", "APR 21, 2016", "APR 18, 2016", "APR 12, 2016", "MAR 31, 2016", "MAR 21, 2016", "MAR 16, 2016", "MAR 7, 2016", "JUL 22, 2016", "MAR 3, 2016", "JAN 5, 2016", "OCT 13, 2015", "APR 14, 2015", "APR 13, 2015", "MAR 5, 2015", "NOV 12, 2014", "MAR 3, 2016", "SEP 29, 2014", "APR 15, 2014", "FEB 14, 2014", "JAN 28, 2014", "JAN 28, 2014", "JAN 21, 2014", "JAN 16, 2014", "SEP 29, 2014", "JAN 9, 2014", "JAN 9, 2014", "JAN 8, 2014", "JAN 7, 2014", "JAN 7, 2014", "DEC 30, 2013", "DEC 27, 2013", "JAN 15, 2014", "DEC 19, 2013", "DEC 19, 2013", "DEC 19, 2013", "DEC 19, 2013", "DEC 19, 2013", "DEC 19, 2013", "DEC 19, 2013", "DEC 20, 2013", "NOV 15, 2013", "OCT 21, 2013", "OCT 20, 2013", "AUG 12, 2013", "JUL 5, 2013", "JUN 21, 2013", "MAR 21, 2013", "DEC 5, 2013", "NOV 14, 2011", "APR 13, 2011", "DEC 27, 2010", "AUG 12, 2010", "JUL 29, 2010", "JUN 29, 2010", "JUN 9, 2010", "NOV 28, 2011"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/alimera-sciences-inc-alim-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-netflix-amazon.com-dish-network-ge-amc-entertainment-aurora", "https://www.nasdaq.com/articles/alimera-sciences-inc-alim-q4-2019-earnings-call-transcript-2020-02-28", "https://www.nasdaq.com/articles/2-healthcare-stocks-set-to-rally-into-the-new-year-2020-01-10", "https://www.nasdaq.com/articles/will-alimera-sciences-alim-report-negative-q4-earnings-what-you-should-know-2019-02-20", "https://www.nasdaq.com/articles/alimera-sciences-alim-reports-q3-loss-tops-revenue-estimates-2018-11-06", "https://www.nasdaq.com/articles/eyepoint-eypt-gets-fda-approval-for-eye-therapy-yutiq-2018-10-17", "https://www.nasdaq.com/articles/alimera-sciences-sees-hammer-chart-pattern%3A-time-to-buy-2018-08-23", "https://www.nasdaq.com/articles/alimera-sciences-inc-alim-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/health-care-sector-update-10232017-alimexacdbvt-2017-10-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vertex-pharmaceuticals-alimera-sciences-enzo-biochem", "https://www.nasdaq.com/articles/alimera-sciences-inc.-alim-looks-good%3A-stock-up-12.8-2017-03-14", "https://www.nasdaq.com/articles/pre-market-most-active-aug-4-2016-nok-chk-azn-sq-cp-foxa-bac-gold-aapl-alim-amrn-xiv-2016", "https://www.nasdaq.com/articles/alimera-sciences-alim-shares-march-higher-can-it-continue-2016-07-27", "https://www.nasdaq.com/articles/health-care-sector-update-07262016-rdyalimtkai-2016-07-26", "https://www.nasdaq.com/articles/health-care-sector-update-07262016-exasalimtkai-2016-07-26", "https://www.nasdaq.com/articles/alimera-stock-grew-25-percent-and-it-just-getting-warmed-2018-07-05", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-april-21st-2016-04-21", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-april-18th-2016-04-18", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-april-12th-2016-04-12", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-31st-2016-03-31", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-21st-2016-03-21", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-16th-2016-03-16", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-7th-2016-03-07", "https://www.nasdaq.com/articles/alimera-sciences-alim-is-in-oversold-territory%3A-whats-next-2016-07-22", "https://www.nasdaq.com/articles/health-care-sector-update-03032016-alimcrmdssh-2016-03-03", "https://www.nasdaq.com/articles/health-care-sector-update-01052016-alimclrbakba-2016-01-05", "https://www.nasdaq.com/articles/alimera-sciences-alim-in-focus%3A-stock-rises-12.3-2015-10-13", "https://www.nasdaq.com/articles/how-bulls-are-playing-alimera-2015-04-14", "https://www.nasdaq.com/articles/is-alimera-sciences-alim-stock-a-solid-choice-right-now-tale-of-the-tape-2015-04-13", "https://www.nasdaq.com/articles/health-care-sector-update-03052015-alimeyesmdbx-2015-03-05", "https://www.nasdaq.com/articles/health-care-sector-update-11122014-casi-ocul-alim-2014-11-12", "https://www.nasdaq.com/articles/closing-update-markets-scratch-out-narrow-wins-ahead-friday-payrolls-report-february-2016", "https://www.nasdaq.com/articles/alimera-psividas-iluvien-receives-fda-approval-for-dme-analyst-blog-2014-09-29", "https://www.nasdaq.com/articles/alimera-psivida-seek-fda-approval-for-iluvien-analyst-blog-2014-04-15", "https://www.nasdaq.com/articles/strength-seen-in-retrophin-rtrx%3A-stock-soars-49.8-tale-of-the-tape-2014-02-14", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2014-01-28", "https://www.nasdaq.com/articles/synthetic-biologics-syn-slumps%3A-stock-tanks-11.4-tale-of-the-tape-2014-01-28", "https://www.nasdaq.com/articles/jnj-beats-on-earnings-but-guides-below-analyst-blog-2014-01-21", "https://www.nasdaq.com/articles/alimera-sciences-alim-jumps%3A-stock-up-7.5-tale-of-the-tape-2014-01-16", "https://www.nasdaq.com/articles/pre-market-most-active-sep-29-2014-tibx-athl-baba-pbr-dwa-tvix-aapl-ecyt-jns-san-bp-alim", "https://www.nasdaq.com/articles/cytori-therapeutics-cytx-soars%3A-stock-adds-11.4-in-session-tale-of-the-tape-2014-01-09", "https://www.nasdaq.com/articles/achillion-pharmaceuticals-achn-surges%3A-stock-moves-13.3-higher-tale-of-the-tape-2014-01-09", "https://www.nasdaq.com/articles/affymetrixs-revenue-guidance-tops-ests-analyst-blog-2014-01-08", "https://www.nasdaq.com/articles/athersys-athx-in-focus%3A-stock-moves-6.3-higher-tale-of-the-tape-2014-01-07", "https://www.nasdaq.com/articles/patients-enrolled-in-synageva-study-analyst-blog-2014-01-07", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2013-12-30", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-alimera-sciences-inc-alim-tale-of-the-tape-2013-12-27", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2014-01-15", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-lower-pre-market-vertex-sinks-phase-3-study-ivacaftor-2013", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-19-1", "https://www.nasdaq.com/articles/update-on-psividas-iluvien-analyst-blog-2013-12-19", "https://www.nasdaq.com/articles/healthcare-stocks-closing-lower-opko-sells-sorrento-therapeutics-stake-10-fold-gain-2009", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-19", "https://www.nasdaq.com/articles/healthcare-stocks-decline-oxygen-biotherapeutics-rallies-plans-bring-heart-drug-late-stage", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-19-0", "https://www.nasdaq.com/articles/alimera-sciences-alim-soars%3A-stock-zooms-62.8-tale-of-the-tape-2013-12-20", "https://www.nasdaq.com/articles/alimera-sciences-inc.-is-now-in-oversold-territory-tale-of-the-tape-2013-11-15", "https://www.nasdaq.com/articles/alimera-down-on-3rd-iluvien-crl-analyst-blog-2013-10-21", "https://www.nasdaq.com/articles/psivida-thoughts-aftermath-complete-response-letter-iluvien-2013-10-20", "https://www.nasdaq.com/articles/trade-earnings-alimera-sciences-inc-2013-08-12", "https://www.nasdaq.com/articles/psivida-starts-phase-iii-study-analyst-blog-2013-07-05", "https://www.nasdaq.com/articles/draft-guidance-from-nice-for-psividas-iluvien-analyst-blog-2013-06-21", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-21-2013-nke-slw-mu-tibx-rue-nwy-alim-2013-03-21", "https://www.nasdaq.com/articles/final-guidance-from-nice-for-psividas-iluvien-analyst-blog-2013-12-05", "https://www.nasdaq.com/articles/limit-your-risk-smart-money-stock-picks-strong-cash-positions-2011-11-14", "https://www.nasdaq.com/articles/these-3-forgotten-ipos-could-gain-much-50-2011-04-13", "https://www.nasdaq.com/articles/options-update-psividia-calls-heat-despite-fda-related-drug-woes-2010-12-27", "https://www.nasdaq.com/articles/7-beaten-down-ipos-could-stage-comeback-2010-08-12", "https://www.nasdaq.com/articles/most-speculative-stocks-market-2010-07-29", "https://www.nasdaq.com/articles/tuesday-winners-worthington-industries-smithfield-foods-and-alimera-sciences-2010-06-29", "https://www.nasdaq.com/articles/these-broken-ipos-may-be-worth-another-look-2010-06-09", "https://www.nasdaq.com/articles/smart-money-cash-rich-companies-boosted-institutional-and-insider-buying-2011-11-28"], "Content": []}